logo

EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link:  https://ebookbell.com/faq 


We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.


For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

From Morphological Imaging To Molecular Targeting Implications To Preclinical Development 1st Edition M Schwaiger

  • SKU: BELL-4461576
From Morphological Imaging To Molecular Targeting Implications To Preclinical Development 1st Edition M Schwaiger
$ 31.00 $ 45.00 (-31%)

5.0

98 reviews

From Morphological Imaging To Molecular Targeting Implications To Preclinical Development 1st Edition M Schwaiger instant download after payment.

Publisher: Springer-Verlag Berlin Heidelberg
File Extension: PDF
File size: 3.96 MB
Pages: 196
Author: M. Schwaiger, W. Weber (auth.), Markus Schwaiger, Ludger Dinkelborg, Hermann Schweinfurth (eds.)
ISBN: 9783662073100, 9783662073124, 3662073102, 3662073129
Language: English
Year: 2004
Edition: 1

Product desciption

From Morphological Imaging To Molecular Targeting Implications To Preclinical Development 1st Edition M Schwaiger by M. Schwaiger, W. Weber (auth.), Markus Schwaiger, Ludger Dinkelborg, Hermann Schweinfurth (eds.) 9783662073100, 9783662073124, 3662073102, 3662073129 instant download after payment.

The current progress in molecular medicine allows the identification of a plethora of new and often human-specific drug targets. An early in vivo validation of specific ligands binding to these targets in humans is needed to assess their potential for targeted imaging and radiotherapy. Radiopharmaceuticals are uniquely suitable for such target validation studies. The purpose of the Ernst Schering Research Foundation Workshop 48 was to offer a forum for an open exchange on the state of the art in the early development of such radiopharmaceuticals. Experts from academia, industry and regulatory authorities provided contributions covering the identification of targets, the necessary preclinical studies on the safety of ligands as well as their validation in human clinical trials.

Related Products